Insights

US market leadership Leverage Lupin's strong US presence as a proven partner for branded and generic formulations, with opportunities to expand product approvals, co-development, and contract manufacturing for high-demand therapeutic areas such as Cardiovascular, Diabetology, and Anti-Infective segments.

FDA approvals Target Lupin’s recent FDA approvals (Eribulin Mesylate Injection, sodium/magnesium sulfate and potassium chloride tablets) to propose supplementary lines, exclusive distribution deals, or faster market entry collaborations in the US for compatible generics and specialty injectables.

Global footprint Capitalize on Lupin’s transnational reach by offering cross-border manufacturing, tech transfer, and API supply arrangements to support global launches, especially in Japan and emerging markets where Lupin holds leadership positions.

Pipeline momentum Position collaborations around Lupin’s Phase 1 assets and oncology-related programs (e.g., LNP8701) to co-develop or license late-stage opportunities, accelerating time-to-market for innovative therapies.

Technology edge Propose data-driven partnerships leveraging Lupin’s tech stack (Collibra, Node.js, Chart.js) for digital health solutions, pharmacovigilance improvements, and advanced analytics to optimize formulation development, regulatory submissions, and market access strategies.

Similar companies to Lupin

Lupin Tech Stack

Lupin uses 8 technology products and services including ISO, ISO 13485, Collibra, and more. Explore Lupin's tech stack below.

  • ISO
    Certificates
  • ISO 13485
    Certificates
  • Collibra
    Data Management Platforms
  • Ariser
    Digital Asset Management
  • Amazon
    E-commerce
  • ADP
    Human Resource Management System
  • Chart.js
    Javascript Graphics
  • Node.js
    Programming Languages

Media & News

Lupin's Email Address Formats

Lupin uses at least 1 format(s):
Lupin Email FormatsExamplePercentage
FirstLast@lupin.comJohnDoe@lupin.com
95%
FirstLas@lupin.comJohnDoe@lupin.com
3%
LastFir@lupin.comDoeJoh@lupin.com
1%
FirLast@lupin.comJohDoe@lupin.com
1%

Frequently Asked Questions

Where is Lupin's headquarters located?

Minus sign iconPlus sign icon
Lupin's main headquarters is located at B/4 Laxmi Towers, Bandra Kurla Complex, Bandra (E), Mumbai, Maharashtra 400 051 IN. The company has employees across 5 continents, including AsiaNorth AmericaSouth America.

What is Lupin's stock symbol?

Minus sign iconPlus sign icon
Lupin is a publicly traded company; the company's stock symbol is LUPIN.NS.

What is Lupin's official website and social media links?

Minus sign iconPlus sign icon
Lupin's official website is lupin.com and has social profiles on LinkedIn.

What is Lupin's NAICS code?

Minus sign iconPlus sign icon
Lupin's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Lupin have currently?

Minus sign iconPlus sign icon
As of February 2020, Lupin has approximately 10K employees across 5 continents, including AsiaNorth AmericaSouth America. Key team members include Vice President Quality: M. S.President: R. S.President - Global Human Resources: Y. G.. Explore Lupin's employee directory with LeadIQ.

What industry does Lupin belong to?

Minus sign iconPlus sign icon
Lupin operates in the Pharmaceutical Manufacturing industry.

What technology does Lupin use?

Minus sign iconPlus sign icon
Lupin's tech stack includes ISOISO 13485CollibraAriserAmazonADPChart.jsNode.js.

What is Lupin's email format?

Minus sign iconPlus sign icon
Lupin's email format typically follows the pattern of FirstLast@lupin.com. Find more Lupin email formats with LeadIQ.

When was Lupin founded?

Minus sign iconPlus sign icon
Lupin was founded in 1968.

Lupin

Pharmaceutical ManufacturingMaharashtra, India10001+ Employees

Lupin is a multinational pharmaceutical manufacturer based in Mumbai, India. The company focuses on developing and delivering a broad array of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients, with notable strengths across cardiovascular, diabetology, asthma, pediatric, CNS, GI, anti-infective, and NSAID markets, and a leadership position in the anti-TB segment. Its offerings aim to provide access to affordable, quality medicines across global markets, serving customers that require both established generics and innovative formulations. Lupin operates across the pharmaceutical industry with a footprint that spans multiple regions, including the United States, India, and Japan, and it positions itself as an innovation-led, transnational player in generic and branded drug development. The company is based in Bandra Kurla Complex, Mumbai, and has a sizable workforce, reflecting its scale in manufacturing and development activities. A recent development noted in public announcements includes regulatory approvals and product launches in the United States and China, indicating ongoing expansion and regulatory progress for its portfolio. } }# end of json }}

Section iconCompany Overview

Headquarters
B/4 Laxmi Towers, Bandra Kurla Complex, Bandra (E), Mumbai, Maharashtra 400 051 IN
Website
lupin.com
Stock Symbol
LUPIN.NS
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1968
Employees
10001+

Section iconFunding & Financials

  • $10M

    Lupin's revenue is estimated to be in the range of $10M

Section iconFunding & Financials

  • $10M

    Lupin's revenue is estimated to be in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.